TAK fundamentals
An in-depth look to Takeda Pharmaceutical Company Limited operating, investing, and financing activities
TAK free cash flow for Q2 24 is 1.35 B USD. For 2023, TAK free cash flow was 3.22 B USD and operating cash flow was 4.43 B USD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM